MARLBOROUGH, Mass.,
Jan. 25, 2021 /PRNewswire/ --
Candela, a leading global medical aesthetic device company, today
announced the availability of the Frax Pro™ system. The
FDA-cleared, non-ablative fractional device is the first platform
featuring dual-depth skin resurfacing with both Frax 1550™ and the
novel Frax 1940™ applicators. The two modalities target
different skin layers, stimulating growth of new collagen,
revealing smoother, more brilliant skin. The Frax 1940 handpiece
delivers a 1940 nm wavelength laser beam for a shallow, epidermal
approach, with focal reach extending to approximately 200 μm
in depth. The 1550 nm wavelength of the Frax 1550 handpiece
penetrates deeper, with histological analysis showing up to 800 μm
penetration. Clinical studies demonstrate high rates of textural
improvement and patient satisfaction with the Frax 1550 and Frax
1940 handpieces.
"With use of both applicators achieving dual depth resurfacing,
we saw a complementary effect," says Jill
Waibel, MD of Miami Dermatology and Laser Institute.
"Additionally, patients treated in our clinic were extremely
pleased with new Frax 1940 treatment results. The outcomes clearly
demonstrated intended results of skin resurfacing with improvement
in both textural irregularities and skin tone."
The Frax Pro system revolutionizes the aesthetic space by
removing limitations of earlier fractional 1550 nm, 1565 nm and/or
1927 nm laser systems. High return on investment (ROI) treatments
of the Frax Pro system make it a wise approach to managing practice
costs when compared to a leading competitive device. The Frax Pro
system's exclusive 100% applicator-confined diode laser technology
and a reductive design, allows a lightweight, flexible umbilical
for a comfortable, ergonomic reach and improved treatment
visibility relative to thulium-based systems. Multiple laser scan
widths enable more customized treatments. These innovations, along
with magnetic roller sensing technology and integrated clinical
intelligence for quick learning and data retrieval, are just some
of the ways that the Frax Pro system advances the space of
non-ablative fractional laser therapies, making it the "smart way
to Frax".
Both the Frax 1550 and Frax 1940 technologies are also available
on, and interchangeable with, the NordlysTM platform.
This addition makes the Nordlys system the first in its class to
provide dual fractional 1550 nm and 1940 nm wavelengths, as well as
IPL and Nd:YAG capabilities.
"The Frax Pro and Nordlys systems, both with Frax 1550 and Frax
1940 applicators, extend our legacy of innovation in non-ablative
treatments," says Geoffrey Crouse,
Chief Executive Officer of Candela. "Candela has a long history of
technological innovation and bringing to market best-in-class
medical aesthetic energy-based devices, and we are proud to share
this new offering."
For more information about the innovative Frax Pro system or
Nordlys multi-application platform, visit candelamedical.com.
About Candela
Candela Corporation is a leading global medical aesthetic device
company with an extensive product portfolio and a global
distribution footprint. The Company's technology enables physicians
to provide advanced solutions for a broad range of medical
aesthetic applications including hair removal; wrinkle reduction;
tattoo removal; women's health treatments; facial resurfacing;
traumatic and surgical scar treatments; body contouring; improving
the skin's appearance through the treatment of benign vascular and
pigmented lesions; and the treatment of acne, leg veins, and
cellulite. Candela has a wide portfolio of trusted, leading
products, including the Vbeam®, Gentle Family®, CO2RE®, CO2RE
Intima®, Exceed™, Nordlys™, Frax Pro™, Profound®,
PicoWay®, and VelaShape®, as well as other energy-based platforms.
Acquired by Apax Partners in July
2017, the Company markets, services and supports its
products in over 100+ countries. It has offices in the United States, Australia, Canada, China, France, Germany, Hong
Kong, Israel, Italy, Japan,
Korea, Portugal, Spain and the United
Kingdom, and many international distributors.
# # #
Corporate Contact
Danielle Kaslow
Sr. Manager, Global Marketing Communications
Candela Corporation
251 Locke Drive, Marlborough, MA
01752
(508) 861-8236
daniellek@candelamedical.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/candela-announces-the-launch-of-the-frax-pro-system-the-smart-way-to-frax-301213558.html
SOURCE Candela Corp